PKU HealthCare Corp.,Ltd. (SHE:000788)
China
· Delayed Price · Currency is CNY 6.14
-0.05 (-0.81%)
Mar 11, 2026, 9:35 AM CST
PKU HealthCare Corp.,Ltd. Revenue
PKU HealthCare Corp.,Ltd. had revenue of 273.88M CNY in the quarter ending September 30, 2025, a decrease of -47.95%. This brings the company's revenue in the last twelve months to 1.76B, down -15.24% year-over-year. In the year 2024, PKU HealthCare Corp.,Ltd. had annual revenue of 2.06B, down -6.10%.
Revenue (ttm)
1.76B
Revenue Growth
-15.24%
P/S Ratio
2.10
Revenue / Employee
2.28M
Employees
772
Market Cap
3.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.06B | -133.78M | -6.10% |
| Dec 31, 2023 | 2.19B | 116.44M | 5.61% |
| Jan 1, 2023 | 2.08B | -159.42M | -7.13% |
| Jan 1, 2022 | 2.24B | 259.35M | 13.12% |
| Dec 31, 2020 | 1.98B | -531.66M | -21.19% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Harbin Medisan Pharmaceutical | 874.60M |
| Huaren Pharmaceutical | 1.26B |
| Zhejiang Cheng Yi Pharmaceutical | 790.86M |
| Shanghai MicuRx Pharmaceutical | 141.77M |
| Nanjing Well Pharmaceutical Group | 1.31B |
| Tuoxin Pharmaceutical Group | 367.49M |
| Shaanxi Panlong Pharmaceutical Group Limited By Share | 1.10B |
| Anhui Sunhere Pharmaceutical Excipients | 934.72M |